Subcutaneous formulations of anti-CD38 antibodies and their uses | Patent Publication Number 20200231697

US 20200231697 A1

Patent NumberUS 11566079 B2

Application Number16840153

Filled DateApr 3, 2020

Priority DateNov 3, 2015

Publication DateJul 23, 2020

Original AssigneeJohnson & Johnson

Current AssigneeJanssen Biotech Inc.

Inventor/ApplicantsVineet Kumar
Richard Jansson

Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Check our Latest Report Purchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.